blood clot

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

Researchers link a missense mutation in the B4GALT1 gene to lower levels of LDL cholesterol and the blood clotting factor fibrinogen.

Health Canada has given the single COVID-19 shot the official greenlight for use in people 18 and older.

Microclots in blood plasma may be behind Long COVID’s chronic symptoms.

COVID-19 affects far more than just the lungs. Researchers are actively documenting the damage the disease causes to the heart, brain, liver, and much more.

Researchers’ painstaking examinations have begun to reveal how the virus wreaks havoc in multiple organs and tissues.

Research in mice and humans points to oxidative stress and inflammation as likely drivers of noise-induced health effects such as hypertension and heart disease.

Sound from cars, aircraft, trains, and other man-made machines is more than just annoying. It increases the risk of cardiovascular disease.

The chance of developing cerebral venous sinus thrombosis was nearly 10 times higher in the two weeks following a diagnosis of SARS-CoV-2 infection than after receiving an mRNA vaccine, a data analysis finds.

The FDA and CDC are investigating a handful of reports of blood clots that occurred several days after people received the one-and-done shot.

The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.

A pathologist describes his observations from examining the bodies of those who succumbed to the coronavirus.

The cholesterol-lowering drugs quell inflammation and reverse endothelial tissue damage, hints that they might curb the body’s excessive immune response to SARS-CoV-2 infection.

These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.

Canines treated with an adeno-associated viral (AAV) vector showed evidence that the therapeutic DNA held within the virus can integrate into the host genome, risking the activation of oncogenes.

Researchers identify two blood-clotting proteins that could be biomarkers for cardiovascular reactions in patients with leprosy.

A failing heart is easily distinguished from a healthy one by numerous tell-tale signs, including its slender, stretched-out walls, increased size, and pooled blood clots.